Photo of Allan Lipton
Contact Expert

View Scopus Profile

Allan Lipton, MD

    • 24913 Citations
    • 77 h-Index
    1969 …2018
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Dive into the research topics where Allan Lipton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 8 Similar Profiles
    zoledronic acid Medicine & Life Sciences
    Breast Neoplasms Medicine & Life Sciences
    Bone and Bones Medicine & Life Sciences
    Diphosphonates Medicine & Life Sciences
    Neoplasm Metastasis Medicine & Life Sciences
    pamidronate Medicine & Life Sciences
    Aminoglutethimide Medicine & Life Sciences
    Neoplasms Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 1969 2018

    6 Citations (Scopus)

    High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts

    Lipton, A., Leitzel, K., Ali, S. M., Polimera, H., Nagabhairu, V., Marks, E., Richardson, A. E., Krecko, L., Ali, A., Koestler, W., Esteva, F. J., Leeming, D. J., Karsdal, M. A. & Willumsen, N., Dec 1 2018, In : International Journal of Cancer. 143, 11, p. 3027-3034 8 p.

    Research output: Contribution to journal › Article

    Metalloproteases
    Extracellular Matrix
    Collagen
    Breast Neoplasms
    Collagen Type III
    3 Citations (Scopus)

    The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis

    Gineyts, E., Bonnet, N., Bertholon, C., Millet, M., Pagnon-Minot, A., Borel, O., Geraci, S., Bonnelye, E., Croset, M., Suhail, A., Truica, C., Lamparella, N., Leitzel, K., Hartmann, D., Chapurlat, R., Lipton, A., Garnero, P., Ferrari, S., Clézardin, P. & Rousseau, J. C., Nov 1 2018, In : Calcified Tissue International. 103, 5, p. 567-580 14 p.

    Research output: Contribution to journal › Article

    Bone Neoplasms
    Biomarkers
    Breast Neoplasms
    Neoplasm Metastasis
    Bone and Bones
    43 Citations (Scopus)

    Continued treatment effect of zoledronic acid dosing every 12 vs 4 weeks in women with breast cancer metastatic to bone: The OPTIMIZE-2 randomized clinical trial

    Hortobagyi, G. N., Van Poznak, C., Harker, W. G., Gradishar, W. J., Chew, H., Dakhil, S. R., Haley, B. B., Sauter, N., Mohanlal, R., Zheng, M. & Lipton, A., Jul 1 2017, In : JAMA Oncology. 3, 7, p. 906-912 7 p.

    Research output: Contribution to journal › Article

    zoledronic acid
    Randomized Controlled Trials
    Breast Neoplasms
    Bone and Bones
    pamidronate
    3 Citations (Scopus)

    Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)

    Ho, D., Huang, J., Chapman, J. A. W., Leitzel, K., Ali, S. M., Shepherd, L., Parulekar, W. R., Ellis, C. E., Crescnzo, R. J., Zhu, L., Virk, S., Nomikos, D., Aparicio, S., Gelmon, K. A., Carney, W. P. & Lipton, A., Aug 1 2017, In : Breast Cancer Research and Treatment. 164, 3, p. 571-580 10 p.

    Research output: Contribution to journal › Article

    Tissue Inhibitor of Metalloproteinase-1
    Breast Neoplasms
    Biomarkers
    Serum
    lapatinib
    4 Citations (Scopus)

    Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor–positive breast cancer: NCIC CTG MA.27

    Lipton, A., Chapman, J. A. W., Leitzel, K., Garg, A., Pritchard, K. I., Ingle, J. N., Budd, G. T., Ellis, M. J., Sledge, G. W., Rabaglio, M., Han, L., Elliott, C. R., Shepherd, L. E., Goss, P. E. & Ali, S. M., Jul 1 2017, In : Cancer. 123, 13, p. 2444-2451 8 p.

    Research output: Contribution to journal › Article

    Osteoporosis
    Hormones
    Breast Neoplasms
    Disease-Free Survival
    Therapeutics